NeRRe Therapeutics CEO, Dr Mary Kerr, will present at BioTrinity 2017, May 9th, London, UK, The title of the presentation is “NeRRe Therapeutics – a unique Neurokinin antagonist pipeline with the potential to return significant near-term value”2017-04-262018-09-14https://www.nerretherapeutics.com/wp-content/uploads/2018/09/logo.pngNeRRe Therapeuticshttps://www.nerretherapeutics.com/wp-content/uploads/2018/09/logo.png200px200px